Completed NA INTERVENTIONAL 2-arm NCT01750970

Endoscopic Resection of Bladder Tumors

Endoscopic Resection of High Grade(TA, T1, Cis)Non-muscle Invasive Bladder Tumors: Modification of Usual Management of This Resection by Using the Blue Light and Evaluation of the Outcome: Should we Maintain the Dogma of Second Endoscopic Resection as a Principle?

Sponsor: Hopital Foch

Conditions Bladder Tumor

Interventions Endoscopic resection under blue light (Hexvix®)

Updated 5 times since 2017 Last updated: Sep 20, 2016 Started: Nov 30, 2009 Primary completion: Dec 31, 2012 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01750970, this NA trial focuses on Bladder Tumor and remains completed. Sponsored by Hopital Foch, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hopital Foch

Data source: Hopital Foch

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suresnes, France